Therapeutic Category
Anti-malarial
REVITHER
Artemether and lumefantrine anti-malarial tablets for the treatment of uncomplicated Plasmodium falciparum malaria.
Anti-malarial Brand
REVITHER
REVITHER contains artemether and lumefantrine and is indicated for uncomplicated Plasmodium falciparum malaria in adults, children, and infants weighing 5 kg and above.
Dosage Form
Tablets
Route of Administration
Oral
Available Pack Sizes
1 x 24 and 1 x 6
Brand Name
REVITHER
Product Name
REVITHER 20/120
Generic Name
Artemether & lumefantrine tablets 20/120 mg
Dosage Form
Tablets
Pack Size
1 x 24
Therapeutic Indication
REVITHER is indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum in adults, children, and infants weighing 5 kg and above.
Dosage and Method of Administration
Treatment should begin at the time of diagnosis or at the onset of symptoms, preferably after a positive diagnostic test. The first dose should be followed by a second dose after 8 hours. For the following two days, doses should be taken twice daily, morning and evening, 12 hours apart.
Mode of Administration
Oral use. To increase absorption, REVITHER should be taken with food or a milky drink. If food cannot be tolerated, the medicine should still be administered, though systemic exposure may be reduced. If vomiting occurs within 1 hour of dosing, the dose should be repeated. For very young children, tablets may be crushed and mixed with a small amount of semi-solid food or liquid and taken immediately.
Brand Name
REVITHER
Product Name
REVITHER 80/480
Generic Name
Artemether & lumefantrine tablets 80/480 mg
Dosage Form
Tablets
Pack Size
1 x 6
Therapeutic Indication
REVITHER is indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum in adults, children, and infants weighing 5 kg and above.
Dosage and Method of Administration
Treatment should begin at the time of diagnosis or at the onset of symptoms, preferably after a positive diagnostic test. The first dose should be followed by a second dose after 8 hours. For the following two days, doses should be taken twice daily, morning and evening, 12 hours apart.
Mode of Administration
Oral use. To increase absorption, REVITHER should be taken with food or a milky drink. If food cannot be tolerated, the medicine should still be administered, though systemic exposure may be reduced. If vomiting occurs within 1 hour of dosing, the dose should be repeated. For very young children, tablets may be crushed and mixed with a small amount of semi-solid food or liquid and taken immediately.